99 related articles for article (PubMed ID: 25638348)
1. Pancreas Metastasization of Nasal NK/T-Cell Lymphoma: A Case Report.
Zhou C; Bu X; Li X; Liu L; Xie X; Zhuo S; Yin H
Cell Biochem Biophys; 2015 Sep; 73(1):17-20. PubMed ID: 25638348
[TBL] [Abstract][Full Text] [Related]
2. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
3. [A case of natural killer T-cell lymphoma in the nasal cavity].
Sengör A; Ozkarakaş H; Erçin C; Memişoğlu I
Kulak Burun Bogaz Ihtis Derg; 2002; 9(3):216-9. PubMed ID: 12415213
[TBL] [Abstract][Full Text] [Related]
4. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
[TBL] [Abstract][Full Text] [Related]
6. Nasal T cell lymphoma: a rare entity.
Kazi M; Ikram M; Junaid M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
9. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
10. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
11. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
12. Sinonasal NK/T-cell lymphoma.
Hmidi M; Kettani M; Elboukhari A; Touiheme N; Messary A
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):145-7. PubMed ID: 23273887
[TBL] [Abstract][Full Text] [Related]
13. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
15. First report of primary pancreatic natural killer/T-cell nasal type lymphoma.
Liu W; Hua R; Zhang JF; Huo YM; Liu DJ; Sun YW
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):318-22. PubMed ID: 23426534
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal NK/T-cell lymphoma with upper gastrointestinal bleeding: a case report.
Huang KJ; Wang LF; Lee KW; Ho KY; Kuo WR; Tsai KB; Chuang JH
Kaohsiung J Med Sci; 2003 Dec; 19(12):639-43. PubMed ID: 14719563
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
19. Maximum standard uptake value at the biopsy site during (18)F-fluorodeoxyglucose positron emission tomography does not predict the proliferation potential of tumor cells in extranodal natural killer/t cell lymphoma, nasal type.
Ishii Y; Tomita N; Sakata S; Takeuchi K; Tateishi U; Watanabe R; Sakai R; Ishigatsubo Y
Acta Haematol; 2012; 128(2):110-2. PubMed ID: 22760030
[No Abstract] [Full Text] [Related]
20. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
Berk V; Yildiz R; Akdemir UO; Akyurek N; Karabacak NI; Coskun U; Benekli M
Clin Nucl Med; 2008 May; 33(5):365-6. PubMed ID: 18431160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]